Clinical Evidence Summary Toolkit
Clinical evidence summary, state of the art review, benefit-risk framework, evidence gap analysis, literature appraisal worksheets, and 510k clinical evidence section templates.
What You Get
Clinical Evidence Summary Template (FDA 510k and PMA)
Structured clinical evidence summary template for FDA submissions. Covers clinical evidence type and source (clinical investigations, literature, registry data, post-market surveillance), evidence quality assessment, clinical endpoint definitions, summary findings by evidence source, and the overall clinical evidence conclusions that support the indication for use and substantial equivalence arguments.
State of the Art Review Protocol and Report Template
Systematic state of the art review protocol and report template for EU MDR clinical evaluation and FDA submissions. Covers literature search methodology (PubMed, EMBASE, Cochrane), search string documentation, inclusion/exclusion criteria, study quality assessment, data extraction tables, and the state of the art conclusion that benchmarks your device against current clinical practice.
Benefit-Risk Determination Framework Template (EU MDR Annex I)
Benefit-risk determination template aligned with EU MDR Annex I GSPR 1 and ISO 14971 Section 7. Covers benefit characterization (intended clinical benefit, magnitude, probability, duration), risk characterization (identified residual risks, probability, severity), benefit-risk balance analysis, and the overall acceptability conclusion that notified bodies and FDA reviewers evaluate.
Clinical Data Gap Analysis and Evidence Generation Plan
Structured gap analysis framework for identifying missing clinical evidence and planning generation activities. Covers current evidence inventory, evidence requirements by submission type, gap identification methodology, evidence generation options (PMCF, registry, RCT, retrospective study), and the prioritized evidence generation plan with timeline and resource requirements.
Literature Appraisal and Level of Evidence Worksheet
Individual study appraisal worksheet for systematic literature reviews. Covers study design classification (RCT, cohort, case-control, case series), risk of bias assessment (GRADE methodology), clinical relevance evaluation, and the data extraction fields specific to medical device clinical evidence. Pre-formatted for compilation into a state of the art review evidence table.
Clinical Evidence Summary for 510k Submission (SEISMIC Format)
510k clinical evidence summary formatted per FDA guidance on the types of clinical studies. Covers the 510k clinical evidence section structure, valid scientific evidence determination, clinical performance summary, safety data summary, and the statistical analysis summary format that FDA review staff use to evaluate clinical data in 510k submissions.
FAQ
What is required for clinical evidence in a 510k?
FDA requires valid scientific evidence demonstrating substantial equivalence in performance and safety to a predicate. Clinical data is not always required for 510k but is expected when performance cannot be demonstrated through bench testing alone, or when the device has novel features with unknown clinical implications.
What is the difference between clinical evidence and clinical data?
Clinical data is raw data from clinical investigations, literature, registry, or post-market sources. Clinical evidence is the conclusion drawn from evaluating clinical data -- the determination that the data is sufficient in quality and quantity to support the intended use and safety profile.
What format are the documents?
All documents are editable Word and Excel templates ready for direct use in your clinical evaluation file or FDA submission.
Ready to get started?
For informational purposes only. Not legal or regulatory advice. Legal